The prognostic value of POD24 in relapsed/refractory follicular lymphoma-A SCHOLAR-5 analysis.
Saved in:
| Title: | The prognostic value of POD24 in relapsed/refractory follicular lymphoma-A SCHOLAR-5 analysis. |
|---|---|
| Authors: | Limbrick-Oldfield EH; RainCity Analytics Vancouver British Columbia Canada., Kanters S; RainCity Analytics Vancouver British Columbia Canada., Ray MD; Kite, A Gilead Company Santa Monica California USA., Best T; Kite, A Gilead Company Santa Monica California USA., Palivela M; Kite, A Gilead Company Santa Monica California USA., Beygi S; Kite, A Gilead Company Santa Monica California USA., Patel AR; Kite, A Gilead Company Santa Monica California USA., Gribben JG; Barts Cancer Institute London UK., Ghione P; Memorial Sloan Kettering Cancer Center Department of Medicine Lymphoma Service New York New York USA. |
| Source: | EJHaem [EJHaem] 2025 Feb 06; Vol. 6 (1), pp. e1104. Date of Electronic Publication: 2025 Feb 06 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101761942 Publication Model: eCollection Cited Medium: Internet ISSN: 2688-6146 (Electronic) Linking ISSN: 26886146 NLM ISO Abbreviation: EJHaem Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
